the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Generic Strategies in Emerging Markets

Published by Datamonitor Contact us : +1-860-674-8796
Published 2009/08 Content info 55 pages
Product code DC99295
Price From  US $ 3800 Order/Price list
US $ 3800 PDF by E-mail (Single User License)
US $ 9500 PDF by E-mail (Global Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

Introduction

The emerging markets are luring a growing number of pharma companies looking to compensate for the diminishing revenues in developed markets. Latin America and Central and Eastern Europe (CEE) are showing strong growth rates, proving to be lucrative targets for firms aiming to expand their foothold, initially as a generics player, but also providing a foundation for subsequent brand penetration.

Scope of this research

  • Provides an overview of recent events affecting the generics market in the CEE and Latin America
  • Identifies the different barriers and opportunities for growth in the CEE and Latin America
  • Provides insight into the growth drivers of multinational and domestic generic players operating in these regions
  • Identifies key strategies for entrance and expansion in these markets

Research and analysis highlights

Sales growth in the CEE generics market is slowing due to increasing competition among generics players, while the Latin American market continues to grow, with significant room for further expansion. Consequently, the Latin American market offers multinationals a better opportunity due to is comparatively greater growth potential.

Indian generics firms are showing a growing interest in the Latin American generics market, especially Brazil. However, going forward, this may undermine the success of domestic players in this region, as Indian generics companies have a ready source of active pharmaceutical ingredients (APIs) and an established low cost manufacturing base.

Generic penetration across the CEE is consistently high due to the historically poor enforcement of intellectual property (IP) laws. However IP issues and competition from similares (non-bioequivalent drugs) hamper penetration of true generics in Latin America, although new regulations have been implemented to target this issue.

Key reasons to purchase this research

  • Understand how recent events and trends will affect the generics industry in the CEE and Latin America
  • Gain insight into which companies are growing rapidly and which strategies are employed
  • Identify the different benefits of entering the CEE and Latin American markets
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.